Atazanavir exposure in pregnancy
1 February 2008. Related: Pregnancy.
Pregnancy
Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-positive pregnant women
1 February 2008. Related: Pregnancy.
US updates guidelines on use of ARVs during pregnancy (Dec 2007)
1 December 2007. Related: Pregnancy, Guidelines.
Perinatal transmission of HIV in England 2002-2005
1 December 2007. Related: Pregnancy.
Risk factors for in utero or intrapartum mother-to-child transmission in Thailand
1 December 2007. Related: Pregnancy.
Pregnancy shows a positive impact on HIV disease progression
2 October 2007. Related: Pregnancy.
African infants CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine prophylaxis
2 October 2007. Related: Pregnancy.
Low rates of mother to child transmission in the DREAM and MTCT-Plus programmes
2 October 2007. Related: Pregnancy.
Very low transmission rates among breastfeeding women receiving ART
3 September 2007. Related: Conference reports, Pregnancy.
Use of pre-exposure prophylaxis (PrEP) by sero-different couples wanting to conceive a child
3 September 2007. Related: Conference reports, Pregnancy.
Increased incidence of miscarriage with efavirenz use
3 September 2007. Related: Conference reports, Pregnancy.
UK (BHIVA) pregnancy guidelines online for comment (2007)
3 September 2007. Related: Pregnancy, Guidelines.
Increased rates of pre-term delivery are associated with the Initiation of HAART during pregnancy: a single-centre cohort study
3 September 2007. Related: Pregnancy.
Antiretroviral therapy and premature delivery in the United Kingdom and Ireland
3 July 2007. Related: Pregnancy.
Early response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine
3 July 2007. Related: Pregnancy.
Mother to child transmission during exclusive breastfeeding
3 July 2007. Related: Pregnancy.
Surveillance of mother-to-child-transmission programmes: the case for universal screening
3 July 2007. Related: Pregnancy.
Rapid progression in infants infected with HIV despite single dose nevirapine prophylaxis
3 July 2007. Related: Pregnancy.
No benefit of early cessation of breastfeeding in the Zambia Exclusive Breastfeeding Study (ZEBS)
4 May 2007. Related: Conference reports, Pregnancy.
Role of infant feeding and HIV in a severe diarrhoea outbreak in Botswana
4 May 2007. Related: Conference reports, Pregnancy.
Diarrhoea in uninfected infants of HIV-positive mothers who stop breastfeeding at 6 Months
4 May 2007. Related: Conference reports, Pregnancy.
Post-weaning gastroenteritis and mortality in HIV-uninfected infants receiving antiretroviral prophylaxis
4 May 2007. Related: Conference reports, Pregnancy.
Rates of diarrhoea associated with early weaning among infants in the Kisumu breastfeeding study
4 May 2007. Related: Conference reports, Pregnancy.
Early breastfeeding cessation among infants and risk of serious gastroenteritis: findings from a perinatal prevention trial in Kampala, Uganda
4 May 2007. Related: Conference reports, Pregnancy.
Pregnancy outcomes in the DART trial
4 April 2007. Related: Conference reports, Pregnancy.
12 month response to HAART in women following exposure to prevention of mother to child transmission regimens
4 April 2007. Related: Conference reports, Pregnancy.
Response to nevirapine containing HAART following single dose nevirapine for PMTCT
5 February 2007. Related: Pregnancy.
US perinatal guidelines updated (2006)
6 December 2006. Related: Pregnancy, Guidelines.
Maternal health and prevention of mother to child transmission
7 October 2006. Related: Conference reports, Pregnancy.
18-month effectiveness of short-course perinatal antiretroviral regimens combined to infant-feeding interventions for PMTCT in DITRAME PLUS ANRS 1201/1202 2001-2005
7 October 2006. Related: Conference reports, Pregnancy.
HIV prevalence rates amongst 6 week old infants in South Africa: the case for universal screening at immunisation clinics
7 October 2006. Related: Conference reports, Pregnancy.
Maternal illness during pregnancy is associated with In utero mother to child transmission
7 October 2006. Related: Conference reports, Pregnancy.
Effect of pregnancy on PK of protease inhibitors
11 June 2006. Related: Conference reports, Pregnancy.
Pharmacokinetics of antiretrovirals in pregnancy: tenofovir, nelfinavir, lopinavir/r
13 April 2006. Related: Conference reports, Pregnancy.
Risk of central nervous system birth defects associated with ART exposure during pregnancy
13 April 2006. Related: Conference reports, Pregnancy.
No increase in adverse pregnancy outcomes in Thai women receiving nevirapine-containing HAART
13 April 2006. Related: Conference reports, Pregnancy.
Association of HIV replication capacity with mother to child transmission
13 April 2006. Related: Conference reports, Pregnancy.
Association between HIV subtype and detection of K103N
13 April 2006. Related: Conference reports, Pregnancy, Drug resistance.
The effect of repeated single-dose nevirapine for PMTCT in a second pregnancy
25 March 2006. Related: Conference reports, Pregnancy.
Should criteria for initiation of HAART be revisited in pregnant women?
25 March 2006. Related: Conference reports, Pregnancy.
Cotrimoxazole prophylaxis in pregnancy
25 March 2006. Related: Conference reports, Pregnancy.
Pregnancy studies at EACS
13 December 2005. Related: Conference reports, Pregnancy.
US pregnancy guidelines updated (Dec 2005)
13 December 2005. Related: Pregnancy, Guidelines.
Breast milk, HIV suppression and decreased mother to child transmission
13 October 2005. Related: Pregnancy.
Single dose nevirapine infant prophylaxis to reduce mother to child transmission may have similar efficacy to maternal and infant doses
13 October 2005. Related: Pregnancy.
Benefits of adding 4 or 7 days of AZT/3TC to single-dose nevirapine to prevent MTCT: further analysis from TOPS
14 September 2005. Related: Conference reports, Pregnancy.
New drugs in pregnancy: atazanavir; T20
14 September 2005. Related: Conference reports, Pregnancy.
US Preventative Services Task Force recommends screening all pregnant women for HIV
13 September 2005. Related: Pregnancy.
Resistance during MTCT strategies: new data on protective benefit of Combivir added to single-dose nevirapine, and impact of treatment and breastfeeding on the infant
15 July 2005. Related: Conference reports, Pregnancy.
Use of T-20 in pregnancy: case study shows transmission occurred in highly treatment experienced mother with multiple-drug resistance
14 July 2005. Related: Pregnancy.
Further reading on nevirapine resistance
14 July 2005. Related: Pregnancy.
Long-awaited UK pregnancy guidelines now updated; pregnancy studies in Dublin
15 June 2005. Related: Conference reports, Pregnancy.
Developments in nevirapine use in MTCT reduction
18 April 2005. Related: Conference reports, Pregnancy.
Mashi study – late breakers on breastfeeding
18 April 2005. Related: Conference reports, Pregnancy.
Maternal health and infant mortality
18 April 2005. Related: Conference reports, Pregnancy.
Nevirapine associated adverse events in a cohort of pregnant women
29 March 2005. Related: Conference reports, Pregnancy.
Indinavir not recommended in pregnancy due to reduced pharmacokinetic levels
29 March 2005. Related: Antiretrovirals, Pregnancy.
Study raises questions about cost effectiveness of nevirapine regimen
6 November 2004. Related: Pregnancy.
Low effectiveness of nevirapine to reduce MTCT in real life situation
6 November 2004. Related: Pregnancy.
Use of T-20 at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough
6 November 2004. Related: Pregnancy, Other news.
MTCT programmes in South Africa: nevirapine and the minister
6 September 2004. Related: Conference reports, Treatment access, Pregnancy.
Adding Combivir to single dose nevirapine for reduction of MTCT significantly reduces resistance
6 September 2004. Related: Conference reports, Pregnancy.
Lopinavir/r levels reduced during pregnancy
6 September 2004. Related: Conference reports, Pregnancy.
Persistent nevirapine resistance following mother to child transmission interventions
29 July 2004. Related: Conference reports, Pregnancy, Drug resistance.
Tipranavir resistance and viral response: L90M did not reduce response, recommendation to use with T-20
29 July 2004. Related: Conference reports, Pregnancy, Drug resistance, Other news.